🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

OVID OVID

Company Profile ↓
$2.62
+427.16% 1Y
Mkt Cap$341.08M
P/E-11.39
P/B2.61
52W High$2.96
52W Low$0.50
Book Value$1.00
EPS (TTM)$-0.23

Company Overview

OVID (OVID) is a publicly traded company listed on with a market capitalization of $341.08M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.10.

Recent Developments

  • Dec 2025 Revenue of $7.25M (+1181.3% YoY); net profit $-17.41M.
  • Trailing 12 Months Year-on-year growth — revenue +1181.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR -12.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-12.93%
1 Year:1,181.27%

Stock Price Performance

1 Year:+427.16%
6 Months:+69.03%
3 Months:-7.42%
1 Month:-5.07%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 86% of range
$0.50 $2.96
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)58.53 · Neutral
Price Performance
1M-5.07%
3M-7.42%
6M+69.03%
1Y+427.16%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -12.9% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-11.39
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$1.00
Price to Book
2.61
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-12.93%
Profit 5Y
-
Revenue (YoY)
1,181.27%
Earnings (YoY)
-

Profitability & Returns

ROCE
-29.75%
ROE
-13.33%
ROA
-11.54%
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.12
EPS (TTM)
$-0.23

Balance Sheet & Liquidity

Debt/Equity
0.10
Quick Ratio
-
Current Ratio
8.97
Debt
$13.42M
Total Assets
$225.63M
Current Assets
$160.15M
Working Capital
$66.08M

Ownership

Promoter Holding
7.04%
Chg in Prom Hold
0.00%
FII / Inst Holding
64.49%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$7.25M
EBITDA
$-42.17M
Free Cash Flow
$-38.33M
Operating Cash Flow
$-38.33M
Shares Outstanding
130.18M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ----------------------1.45M011.10K66.00K75.00K109.00K148.00K169.00K173.00K130.00K6.27M132.00K718.00K0
Cost of Revenue ------------------------------------
Gross Profit ------------------------------------
Operating Expenses -------------------------------12.68M11.35M12.65M13.01M17.85M
Operating Income --5.42M-5.81M--34.26M-10.29M-9.41M--13.43M-13.21M-13.18M--14.05M-13.32M-16.77M--20.29M-23.14M-16.40M176.56M-14.31M-11.68M-16.27M-14.30M-12.80M-14.89M-14.17M-12.03M-17.42M-20.52M-13.23M-12.55M-5.07M-12.52M-12.29M-17.85M
EBITDA --------------------------------12.41M-4.97M-12.51M-12.28M-17.81M
Interest Expense ------------------------------------
Pretax Income --------------------------------10.23M-4.68M-12.16M9.66M-16.99M
Tax Provision -------------------------------00000
Net Income -3.68M-5.39M-5.79M-7.56M-34.24M-10.25M-9.36M-10.96M-13.18M-12.94M-12.96M-12.90M-13.80M-13.06M-16.63M-16.97M-20.03M-22.55M-16.42M176.01M-15.79M-11.38M-16.11M-14.59M-11.97M-13.36M-12.41M-11.25M-11.69M8.52M-14.01M-10.23M-4.68M-12.16M9.66M-16.99M
Diluted EPS -----------------0.37-0.41-0.282.53-0.23-0.17-0.23-0.21-0.17-0.19-0.18-0.16-0.170.12-0.20-0.14-0.06-0.170.06-0.12
R&D Expense 1.13M1.77M2.70M-31.28M6.07M5.90M-8.47M8.12M8.54M-9.34M9.12M11.60M-14.63M16.03M15.88M16.25M7.68M4.92M7.83M6.05M5.18M6.62M6.00M5.33M10.40M12.58M7.86M6.66M6.46M5.87M-11.18M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -----12.62M-1.50M392.00K566.00K7.25M
Cost of Revenue -----------
Gross Profit -----------
Operating Expenses -------57.05M59.67M62.45M49.69M
Operating Income -13.19M-22.54M-65.01M-52.93M-61.41M-81.43M--55.55M-59.28M-61.88M-42.44M
EBITDA --------54.17M-58.71M-61.27M-42.17M
Interest Expense -----------
Pretax Income --------54.17M-52.34M-26.43M-17.41M
Tax Provision -------0000
Net Income -13.16M-22.41M-64.81M-51.98M-60.46M-81.04M--54.17M-52.34M-26.43M-17.41M
Diluted EPS ------1.39--0.77-0.73-0.37-0.23
R&D Expense 6.61M9.59M49.97M33.79M42.16M63.42M46.94M24.62M28.59M36.77M25.58M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --53.03M89.46M47.65M80.84M75.93M-155.27M144.03M92.17M150.93M
Current Assets --------131.38M109.60M55.94M74.37M
Cash & Equivalents 4.85M69.94M51.94M87.13M36.49M41.90M72.03M-44.87M27.04M26.30M13.15M
Inventory ------------
Receivables -------0----
Total Liabilities ----8.84M10.82M32.29M-22.99M56.23M23.94M20.27M
Current Liabilities --3.73M6.02M8.84M10.53M22.06M-6.99M11.47M10.52M8.29M
Long Term Debt ------------
Total Debt --------16.54M16.00M14.76M13.42M
Total Equity 4.74M68.07M49.29M83.44M38.81M70.02M43.63M-132.27M87.80M68.23M130.66M
Shares Outstanding --------70.47M70.69M71.01M130.18M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow ---31.47M-45.56M-51.09M-51.58M--55.23M-45.78M-55.96M-38.33M
Investing Cash Flow ---47.39K-5.36M-30.04M34.65M--87.88M-2.58M54.59M-49.85M
Financing Cash Flow --66.70M286.14K86.54M47.07M-180.66K30.54M622.00K75.21M
Capital Expenditure -32.08K-30.36K-38.91K-33.87K-57.16K-127.24K-189.41K-1.42M-137.00K-161.00K-
Free Cash Flow ---31.51M-45.59M-51.15M-51.71M--56.65M-45.92M-56.12M-38.33M
Net Change in Cash --------142.93M-17.83M-740.00K-12.98M

Ratios (Annual)

Figures in %.

Metric Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------
Operating Margin % ------645.4%--3,696.4%-15,122.7%-10,933.7%-585.2%
Net Margin % ------642.3%--3,604.7%-13,351.8%-4,670.1%-240.1%
ROE % -19.3%-45.5%-77.7%-134.0%-86.3%-185.7%--41.0%-59.6%-38.7%-13.3%
ROCE % --45.7%-77.9%-136.4%-87.3%-151.2%--37.5%-44.7%-75.8%-29.8%

Shareholding Pattern

Insiders
7.04%
Institutions
64.49%
Public Float
69.37%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for OVID

Google News Wed, 05 Aug 2026

Ovid Therapeutics Inc. (OVID) Stock Price, News, Quote & History - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTFBSV3RPM0c0Uks2a1pVTy1BdUczTzhMbkliWVN1M3NfWTlqeG9tdXFrbHZsanpvVnZQc1RJODZUeU1uamZSTTFkTktpdkpKUQ?oc=5" target="_blank">Ovid Therapeutics Inc. (OVID) Stock Price, News, Quote & Hist…

Google News Fri, 26 Jun 2026

OVID Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBMeGhBS0p4SWhoeDJGTC1ZN0Fvb3VDeVNJeGQ5SWlleGU4N1N3cmI3ZmczOFR4bGRjRmFyVFBlWHIyUnI0RHBFcEZvNTJiRHRhTmE0dXR5WFRYQ2E3d2NRQVkyYVQ1Q1VFVHdFM0RGUXllX082VUcxcGZB?oc=5" target="_blank">OVI…

Google News Wed, 05 Aug 2026

Earnings Preview: Ovid Therapeutics (OVID) Q2 Earnings Expected to Decline - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxORGpiNnBKNmp2ZTE3VXJtSzViandXSXdMekJvM0ZjOW4yNGFrNEpSbmtQWXVIYlU3d0cwZDY5VEQtd3RQZXBYVENWdzJwRUhMVGVvenh1RWZPeDdoMk0tRFZuT1pLZS1mWEFtU19jdlpqUG5IMmhtdXZraThUTmQ1MnQxcWhEM2dFSFI5cW…

Google News Mon, 03 Aug 2026

OVID Maintained by Oppenheimer -- Price Target Raised to $9.00 - GuruFocus

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPTTBKRE9SVF92b19KYnp2RDZkZEdyN1RER1ROMDBZRk1WbHZEeHdoZ2lJZnFMVFU0amdGRDM0MThnc2N0dUZycDRoeVRycVNxMXdQT0NlTkd2Zkg1MmxzU0ZRYmFZbFhiS1puS243b1oxZzByejZWTWlwMnl5TGRHeHBmQzJYQ0hEZkM4WX…

Google News ue, 04 Aug 2026

Ovid Therapeutics Inc (NASDAQ: OVID) Share Price, OVID Stock News, OVID Share Price & Updates - Kalkine

<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE12Z0hjdFMyMFZ6a2NNSWpmRXhuaGpwSERIeXg4OXZ2TUt2cEp1VXZHb05nR0Q0T0U0b3hjaEtRZnBvMTdRTHlOcDhZaGtQaHN5aUpwY0lB?oc=5" target="_blank">Ovid Therapeutics Inc (NASDAQ: OVID) Share Price, O…

Google News ue, 07 Apr 2026

$OVID stock is up 9% today. Here's what we see in our data. | OVID Stock News - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNdkkwZTEtTmxTekdrX0U1T0RlLXpCc1ZheDlxbVNMMXNLZTBMd3FXbVAzYmNhRVZMUmVLSGFNc1dQbTEzZ3dDZk1tOTZNeUZSa0pHbFprT3h2QUdHaldMZG5lTkE2aldpVktxTDVjNFBHU3NGeGxKNFk1OWQxUnRWNFRsMEFSN0k3Y2xIYU…

OVID — Frequently Asked Questions

What is the current share price of OVID?

As of 2026-08-05 17:25 PDT, OVID trades at $2.62 on NASDAQ/NYSE. Its 52-week range is $0.50 to $2.96.

What is the market capitalisation of OVID?

OVID has a market capitalisation of $341.08M on NASDAQ/NYSE.

What is the P/E ratio of OVID?

OVID trades at a trailing price-to-earnings (P/E) ratio of -11.39. Its price-to-book (P/B) ratio is 2.61.

What is the return on equity (ROE) of OVID?

OVID has a return on equity (ROE) of -13.33%. Its return on capital employed (ROCE) is -29.75%.

Is OVID a good stock to buy?

This page provides a data-driven analysis of OVID, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space